9 withdrawn. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Withdrawn 9 |
Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia | Phase 4 | Withdrawn | Brigham and Women's Hospital | 2023-09-01 | 2026-01-28 | |
| Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia Clonazepam, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 4 | Withdrawn | Palo Alto Veterans Institute for Research | 2016-10-01 | 2018-04-05 | |
| Study of the Effect of Dosing on Clozapine Levels Clozapine - Psychotic Disorders, Schizophrenia | Phase 4 | Withdrawn | University of British Columbia | 2015-01-01 | 2021-10-08 | |
| Alleviating the Metabolic Side Effects of Antipsychotic Medications Moxonidine, Placebo - Schizophrenia | Phase 4 | Withdrawn | Baker Heart and Diabetes Institute | 2012-05-01 | 2019-04-24 | |
| Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital paliperidone palmitate, risperidone, olanzapine - Schizophrenia | Phase 4 | Withdrawn | Ortho-McNeil Janssen Scientific Affairs, LLC | 2010-08-01 | 2013-07-08 | |
| Once Weekly D-cycloserine for Schizophrenia D-cycloserine, Placebo - Schizophrenia | Phase 4 | Withdrawn | Massachusetts General Hospital | 2009-07-01 | 2013-11-20 | |
| Cardio Risk of Acute Schizophrenia Olanzapine Duke Olanzapine, Metformin, Simvastatin - Schizophrenia, Schizoaffective Disorder | Phase 4 | Withdrawn | Duke University | 2008-04-01 | 2014-07-31 | |
| Safety and Tolerability of Varenicline in Schizophrenia (SATOVA) Varenicline - Schizophrenia, Schizoaffective | Phase 4 | Withdrawn | University of British Columbia | 2008-04-01 | 2017-11-29 | |
| Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal varenicline, Adaptation of Motivational Interviewing - Tobacco Use Disorder | Phase 4 | Withdrawn | VA Boston Healthcare System | 2015-06-04 |
Psychotic Disorders (6) · Smoking Cessation (2) · Tobacco Use Disorder (2) · Bipolar Disorder (1) · Cognitive Dysfunction (1) · Mental Disorders (1) · Psychomotor Agitation (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Smoking (1)
Mental Disorders (8) · Schizophrenia Spectrum and Other Psychotic Disorders (8) · Behavior (3) · Chemically-Induced Disorders (2) · Health Behavior (2) · Substance-Related Disorders (2) · Aberrant Motor Behavior in Dementia (1) · Behavioral Symptoms (1) · Bipolar and Related Disorders (1) · Cognition Disorders (1) · Dyskinesias (1) · Mood Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1)
Olanzapine (2) · Varenicline (2) · Aripiprazole (1) · Clonazepam (1) · Clozapine (1) · Cycloserine (1) · Metformin (1) · Paliperidone Palmitate (1) · Perphenazine (1) · Quetiapine Fumarate (1) · Risperidone (1) · Simvastatin (1) · moxonidine (1)
University of British Columbia (2) · Baker Heart and Diabetes Institute (1) · Brigham and Women's Hospital (1) · Duke University (1) · Massachusetts General Hospital (1) · Ortho-McNeil Janssen Scientific Affairs, LLC (1) · Palo Alto Veterans Institute for Research (1) · VA Boston Healthcare System (1)
United States (4) · Australia (1) · Canada (1)
Alasdair Barr, Ph.D (2) · Ric M. Procyshyn, Ph.D (2) · William Honer, MD (2) · Abdul Khalid (1) · Barbara W Kamholz, Ph.D. (1) · Chris Schenk, MD (1) · David Barton (1) · Donald C Goff, M.D. (1) · Gary B Kaplan, M.D. (1) · Gavin Lambert (1) · James Levitt, M.D. (1) · Joseph P McEvoy, MD (1) · Joyce Coutts, MD (1) · Randall White, MD (1)
P50MH060450 (1)